Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pan-T booster MSLN CAR T in advanced solid tumors
NCT05693844Phase 2Recruiting
- Sponsor
- Chinese PLA General Hospital
- Start
- Jan 2023
- Primary completion
- Dec 2025
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of Pan-T booster co-expressing MSLN CAR T cell in Solid tumors, sponsored by Chinese PLA General Hospital. Started Jan 2023; status: recruiting.
02
Drugs
Pan-T booster co-expressing MSLN CAR T cell
03
Conditions
Solid tumors
Beyond the preview
Go deeper on NCT05693844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05693844.